Of note, Afonso et al. [76] observed, in a different report, that cisplatin-treated bladder cancer patients showed decreased OS (near significant associations) when MCT1 expression occurred in normoxic cancer cells, together with MCT4 expression in hypoxic cancer cells and in stromal cells. Here, SLC16A1 is linked to urinary bladder carcinoma.